Akitada Ichinose Selected Research

Factor XIII Deficiency

5/2022	Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development.
5/2021	Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.
1/2017	Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
7/2015	[Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
11/2014	Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm.
12/2012	Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
9/2012	Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.
1/2012	Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies.
12/2010	Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akitada Ichinose Research Topics

Disease

35	Hemorrhage 11/2022 - 08/2005
10	Hemophilia A (Haemophilia) 01/2022 - 04/2013
9	Factor XIII Deficiency 05/2022 - 12/2010
8	Thrombosis (Thrombus) 01/2020 - 11/2008
3	Inflammation (Inflammations) 05/2022 - 04/2012
2	Confusion (Bewilderment) 01/2022 - 06/2015
2	Infections 01/2020 - 01/2017
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 09/2013
2	Type I Plasminogen Deficiency 08/2016 - 06/2009
2	Carcinoma (Carcinomatosis) 05/2016 - 03/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2016 - 09/2013
2	Rheumatoid Arthritis 04/2016 - 12/2012
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2016 - 07/2015
2	Neoplasms (Cancer) 04/2016 - 11/2015
2	Thrombocytopenia (Thrombopenia) 07/2015 - 11/2014
2	Disseminated Intravascular Coagulation 11/2014 - 09/2013
2	Spontaneous Abortion (Miscarriage) 08/2005 - 12/2003
1	COVID-19 01/2022
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2022
1	Immunoglobulin Light-chain Amyloidosis 04/2020
1	Factor V Deficiency 01/2020
1	Wound Infection (Wound Infections) 01/2020
1	Femoral Fractures (Femoral Fracture) 01/2020
1	Diabetes Mellitus 02/2019
1	Necrosis 02/2019
1	Myocardial Infarction 01/2019
1	Anemia 01/2019
1	Factor X Deficiency 01/2019
1	Hematoma 10/2017
1	Acute Subdural Hematoma 10/2017
1	Hemostatic Disorders 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Neutropenia 01/2017
1	Pulmonary Embolism 01/2017
1	Mucositis 08/2016
1	Purpura 04/2016
1	Esophageal Neoplasms (Esophageal Cancer) 04/2016
1	Autoimmune Diseases (Autoimmune Disease) 07/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015
1	Disease Susceptibility (Diathesis) 07/2015
1	Cardiac Tamponade 06/2015
1	Aortic Aneurysm (Aneurysm, Aortic) 11/2014
1	Abdominal Aortic Aneurysm 09/2013

Drug/Important Bio-Agent (IBA)

18	AutoantibodiesIBA 05/2022 - 04/2013
17	Factor XIII (Coagulation Factor XIII)IBA 01/2022 - 12/2003
10	AntibodiesIBA 03/2022 - 01/2012
5	Blood Coagulation Factors (Coagulation Factor)IBA 05/2022 - 07/2014
4	Factor V (Coagulation Factor V)IBA 03/2022 - 01/2019
4	Hemostatics (Antihemorrhagics)IBA 03/2022 - 06/2015
3	Factor X (Stuart Factor)IBA 03/2022 - 01/2019
3	Factor VIII (Coagulation Factor VIII)IBA 04/2020 - 04/2016
3	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 10/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 06/2015
2	AnticoagulantsIBA 01/2020 - 07/2014
2	Rituximab (Mabthera)FDA Link 01/2017 - 06/2015
2	Fibrinolysin FDA Link 08/2016 - 11/2003
2	tocilizumab (atlizumab)FDA Link 04/2016 - 12/2012
2	Inosine Triphosphate (ITP)IBA 04/2016 - 07/2015
2	Dacarbazine (DIC)FDA LinkGeneric 11/2014 - 09/2013
2	AntithrombinsIBA 07/2014 - 06/2009
2	plasma protein Z (protein Z)IBA 03/2012 - 01/2005
1	von Willebrand FactorIBA 11/2022
1	ProteomeIBA 05/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	CTLA-4 AntigenIBA 01/2021
1	Tranexamic Acid (AMCA)FDA Link 04/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Factor VIIa (Activated Factor VII)IBA 09/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2019
1	SteroidsIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	estropipate (Ogen)FDA LinkGeneric 08/2016
1	Pancreatic Elastase (Elastase)IBA 08/2016
1	PlasminogenIBA 08/2016
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2016
1	Monoclonal AntibodiesIBA 04/2016
1	Prednisone (Sone)FDA LinkGeneric 07/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015
1	Thrombin FDA Link 05/2015
1	Factor XIIIaIBA 05/2015
1	Enzyme Precursors (Zymogens)IBA 05/2015
1	FibrinIBA 05/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015
1	ThrombomodulinIBA 11/2014
1	Protein CIBA 07/2014
1	Protein SIBA 07/2014

Therapy/Procedure

11	Therapeutics 02/2019 - 08/2005
2	Renal Dialysis (Hemodialysis) 01/2020 - 02/2019
2	Plasma Exchange 08/2018 - 01/2013
1	Debridement 01/2020
1	Replacement Arthroplasty 01/2020
1	Thrombectomy 02/2019
1	Thrombolytic Therapy 02/2019
1	Punctures 02/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 08/2018
1	Craniotomy 10/2017
1	Radiotherapy 04/2016
1	Nephrectomy 04/2016
1	Hysterectomy 11/2015